A treatable muscle disease

Pract Neurol. 2009 Aug;9(4):233-6. doi: 10.1136/jnnp.2009.181966.
No abstract available

MeSH terms

  • Age Distribution
  • Aged
  • Disease Progression
  • Ephedrine / pharmacology
  • Ephedrine / therapeutic use
  • Extremities / physiopathology
  • Female
  • Gait Disorders, Neurologic / etiology
  • Gait Disorders, Neurologic / physiopathology*
  • Gait Disorders, Neurologic / therapy*
  • Genetic Predisposition to Disease
  • Horner Syndrome / genetics
  • Humans
  • Muscle Proteins / genetics
  • Muscle Weakness / etiology
  • Muscle Weakness / physiopathology*
  • Muscle Weakness / therapy*
  • Muscle, Skeletal / physiopathology
  • Muscular Diseases / genetics
  • Muscular Diseases / physiopathology*
  • Muscular Diseases / therapy*
  • Myasthenic Syndromes, Congenital / diagnosis
  • Myasthenic Syndromes, Congenital / physiopathology*
  • Myasthenic Syndromes, Congenital / therapy*
  • Neuromuscular Junction / genetics

Substances

  • DOK7 protein, human
  • Muscle Proteins
  • Ephedrine